Doximity Inc
NYSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Doximity Inc
NYSE:DOCS
|
US |
|
Aedifica NV
F:AOO
|
BE |
|
K
|
Ksolves India Ltd
NSE:KSOLVES
|
IN |
|
A
|
Air Products and Chemicals Inc
F:AP3
|
US |
|
O
|
Ocean Bio-Chem Inc
F:OBC
|
US |
|
Nice Ltd
NASDAQ:NICE
|
IL |
|
L
|
L'Oreal SA
F:LOR
|
FR |
|
R
|
Renta 4 Banco SA
F:4RE
|
ES |
|
Inpixon
NASDAQ:XTIA
|
US |
|
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
|
US |
|
QBE Insurance Group Ltd
ASX:QBE
|
AU |
Wall St Price Targets
DOCS Price Targets Summary
Doximity Inc
According to Wall Street analysts, the average 1-year price target for DOCS is 39.18 USD with a low forecast of 25.25 USD and a high forecast of 63 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DOCS's stock price target?
Price Target
39.18
USD
According to Wall Street analysts, the average 1-year price target for DOCS is 39.18 USD with a low forecast of 25.25 USD and a high forecast of 63 USD.
What is the Revenue forecast for Doximity Inc?
Projected CAGR
8%
Over the last 5 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 7 years is 8%.
What is the Operating Income forecast for Doximity Inc?
Projected CAGR
13%
Over the last 5 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 7 years is 13%.
What is the Net Income forecast for Doximity Inc?
Projected CAGR
11%
Over the last 5 years, the compound annual growth rate for Net Income has been 83%. The projected CAGR for the next 7 years is 11%.
